Virginia Solitano
Overview
Explore the profile of Virginia Solitano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abushamma S, Yadete T, Nero N, Falloon K, Parker C, Abreu M, et al.
J Crohns Colitis
. 2025 Mar;
PMID: 40066499
Background And Aims: Over 10% of patients with Crohn's disease require permanent ileostomy. We aimed to summarize the existing data on diagnosis, definitions of recurrence, and management of Crohn's disease...
2.
Sedano R, Solitano V, Vuyyuru S, Yuan Y, Hanzel J, Ma C, et al.
Therap Adv Gastroenterol
. 2025 Feb;
18:17562848251321915.
PMID: 39996136
Integrating artificial intelligence (AI) into clinical trials for inflammatory bowel disease (IBD) has potential to be transformative to the field. This article explores how AI-driven technologies, including machine learning (ML),...
3.
Noor N, Estevinho M, Solitano V, Yuan Y, Kahan B, Jairath V
Lancet Gastroenterol Hepatol
. 2025 Feb;
PMID: 39914434
No abstract available.
4.
Solitano V, Estevinho M, Ungaro F, Magro F, Danese S, Jairath V
BioDrugs
. 2025 Feb;
39(2):171-183.
PMID: 39907869
Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), remains challenging to manage, with a substantial proportion of patients not responding to conventional therapies or developing complications....
5.
Solitano V, Jairath V, Danese S
United European Gastroenterol J
. 2025 Jan;
PMID: 39757894
No abstract available.
6.
Lee H, Solitano V, Singh S, Ananthakrishnan A, Jairath V, Syal G, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39732355
Background And Aims: We sought to ascertain how prior exposure to tumor necrosis factor (TNF) antagonists impacts treatment response with various classes of advanced therapies in patients with ulcerative colitis...
7.
Solitano V, Narula N, Ma C, Nanayakkara A, Suarez K, Zoughlami A, et al.
Am J Gastroenterol
. 2024 Dec;
PMID: 39657015
Introduction: We aimed to evaluate the real-world effectiveness and safety of ustekinumab for the treatment of both bio-naive and bio-exposed ulcerative colitis patients in a real-world setting. Methods: Retrospective, Canadian...
8.
Yuan Y, Sedano R, Solitano V, Nardone O, Crowley E, Jairath V
United European Gastroenterol J
. 2024 Nov;
12(10):1481-1488.
PMID: 39541219
Crohn's Disease (CD) can affect any part of the gastrointestinal (GI) tract, including the upper GI tract (UGIT). However, the definitions and classifications of upper GI CD (UGICD) vary. We...
9.
Solitano V, Zou G, Jairath V
Aliment Pharmacol Ther
. 2024 Nov;
61(1):236-237.
PMID: 39533661
No abstract available.
10.
Solitano V, Yuan Y, Singh S, Ma C, Nardone O, Fiorino G, et al.
J Autoimmun
. 2024 Nov;
149:103331.
PMID: 39509741
Objectives: Advanced combination treatment (ACT), defined as a combination of at least 2 biologic agents, a biologic agent and an oral small molecule, 2 oral small molecules drug with different...